AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Novel adjuvants promote immunity against blood-stage malaria in mice.

Vaccine Weekly

| November 05, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 NOV 5 - (NewsRx.com & NewsRx.net) -- Novel immunostimulatory adjuvants promoted immunity against blood-stage malaria in mice.

According to a study from Canada, "An important aspect of malaria vaccine development is the identification of an appropriate adjuvant which is both capable of stimulating a protective immune response and safe for use by humans. Here, we investigated the feasibility of using novel immunostimulatory molecules as adjuvants combined with a crude antigen preparation and co-adsorbed to aluminum hydroxide (alum) as a vaccine against blood-stage Plasmodium chabaudi AS malaria."

"Prior to challenge infection, immunization of genetically susceptible A/J mice with the combination of malaria antigen plus recombinant interleukin-12 (IL-12) in alum induced a Th1 immune response with production of high levels of gamma interferon (IFN-gamma) and diminished IL-4 levels by spleen cells stimulated in vitro with parasite antigen compared to mice immunized with antigen alone, antigen in alum, or antigen plus IL-12," reported Zhong Su and collaborators at McGill University. "Mice immunized with malaria antigen plus recombinant IL-12 in alum had high levels of total malaria-specific antibody and immunoglobulin G2a."

"Compared to unimmunized mice, immunization with antigen plus IL-12 in alum induced the highest level of protective immunity against challenge infection with P. chabaudi AS, which was evident as a significantly decreased peak ...

Related articles from newspapers, magazines, journals, and more
Research brief: Malaria vaccine hope.(five vaccines designed to target...
Magazine article from: GP October 20, 2006 700+ words
...The review included 11 studies carried out on more than 3,000 people that tested five vaccines designed to target early-stage malaria. Four of the five vaccines were ineffective, but the RTSS vaccine reduced the number of clinical malaria episodes in children...
Study: Remune antigen with CpG ODN may offer HIV protection.(Brief Article)
Newspaper article from: AIDS Weekly December 16, 2002 700+ words
...Our results suggest that Remune antigen plus CpG ODN when given as a intranasal immunization...CpG ODN. Mice immunized with Remune antigen plus CpG ODN had enhanced levels of anti...intranasal immunization with Remune antigen plus CpG ODN protected mice against intravaginal...
Study: Remune antigen with CpG ODN may offer HIV protection.
Newspaper article from: Vaccine Weekly December 18, 2002 700+ words
...Our results suggest that Remune antigen plus CpG ODN when given as a intranasal immunization...CpG ODN. Mice immunized with Remune antigen plus CpG ODN had enhanced levels of anti...intranasal immunization with Remune antigen plus CpG ODN protected mice against intravaginal...
The Immune Response Corporation Announces Study Suggesting Protection From HIV...
Press release article from: PR Newswire October 17, 2002 700+ words
...Our results suggest that REMUNE(R) antigen plus CpG ODN when given as a intranasal immunization...ODN. Mice immunized with REMUNE(R) antigen plus CpG ODN had enhanced levels of anti...intranasal immunization with REMUNE(R) antigen plus CpG ODN protected mice against intravaginal...
Herpesvirus vaccine aided by calcium phosphate nanoparticle adjuvant.
Newspaper article from: Vaccine Weekly December 11, 2002 700+ words
...immunity after mucosal delivery of a vaccine containing HSV-2 antigen plus CAP. The investigators immunized mice intravaginally and...one of the following four vaccine formulations: HSV-2 antigen plus CAP as an adjuvant (HSV-2+CAP), CAP alone, phosphate...
Herpesvirus vaccine aided by calcium phosphate nanoparticle adjuvant .(Brief...
Newspaper article from: Virus Weekly December 10, 2002 700+ words
...immunity after mucosal delivery of a vaccine containing HSV-2 antigen plus CAP. The investigators immunized mice intravaginally and...one of the following four vaccine formulations: HSV-2 antigen plus CAP as an adjuvant (HSV-2+CAP), CAP alone, phosphate...
Animal Study Suggests Intranasal Delivery of HIV-1 Antigen With Adjuvant May...
Press release article from: PR Newswire February 26, 2002 700+ words
...mice immunized intranasally with the Company's HIV-1 antigen plus CpG ODN immune stimulant had significantly enhanced levels...also significantly higher in mice immunized with HIV-1 antigen plus CpG ODN. Most importantly, the intranasal immunization...
The Immune Response Corp announces study suggesting protection from HIV...
News wire article from: Asia Africa Intelligence Wire October 17, 2002 700+ words
...in combination with CpG ODN. Mice immunized with Remune antigen plus CpG ODN had enhanced levels of anti-p24 IgG and IgA antibodies...study indicated that intranasal immunization with Remune antigen plus CpG ODN protected mice against intravaginal challenge with...
Pancreatic cancer research should focus on antigen presentation, targeted drug...
Newspaper article from: Biotech Week January 8, 2003 700+ words
...herpes simplex virus glycoprotein D2. Immunology, 2002;107(2):268-274). Compared with antigen delivery alone, antigen plus MLI, MLII or MLIII stimulated significantly higher levels of antigen-specific IgA and IgG antibodies. The increases in...
Reports by J.P. Scottbrowne and co-researchers describe recent advances in life...
Newspaper article from: Science Letter May 19, 2009 700+ words
"An alpha beta T-cell response depends on the recognition of antigen plus major histocompatibility complex (MHC) proteins(1) by its antigen receptor (TCR). The ability of peripheral alpha beta...
For more facts and information, see all results

Source: HighBeam Research, Novel adjuvants promote immunity against blood-stage malaria in mice.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA